Thomas Engelbrecht Nordkild Jonassen

Most equity: ResoTher Pharma A/S (2017) '958 DKK

Biggest loss: ResoTher Pharma A/S (2017) '958 DKK

• TJ Biotech Holding II ApS

  Inactive

  
  

  Ultimate beneficial owner (2020-12-14 - 2020-12-30) 100% ownership (2020-12-14 – 2020-12-30 ) 100% voting rights (2020-12-14 – 2020-12-30 )

  Legal owner (2020-12-14 - 2020-12-30) 100% ownership (2020-12-14 – 2020-12-30 ) 100% voting rights (2020-12-14 – 2020-12-30 )

  Director (2020-12-14 - 2020-12-30)

• TENJ BIOTECH ApS

  Inactive

  
  

  Ultimate beneficial owner (2013-05-15 - 2020-12-02) 100% ownership (2013-05-15 – 2020-12-02 ) 100% voting rights (2013-05-15 – 2020-12-02 )

• ResoTher Pharma A/S

  Active

  
  

  Board member (2025-06-23 - present)

  Ultimate beneficial owner (2016-07-04 - 2019-10-28) 20.12% ownership (2019-10-28 – 2019-10-28 ) 25.39% ownership (2017-11-23 – 2019-10-27 ) 41.5% ownership (2016-07-04 – 2017-11-22 ) 20.12% voting rights (2019-10-28 – 2019-10-28 ) 25.39% voting rights (2017-11-23 – 2019-10-27 ) 41.5% voting rights (2016-07-04 – 2017-11-22 )

  Board member (2016-07-04 - 2017-11-23)

  Director (2016-07-04 - 2017-11-23)